2006 News

The UCSF School of Pharmacy has received a US$3.7 million grant from the Amgen Foundation to train student pharmacists in all 7 California schools of pharmacy with the skills they need to help the underserved elderly make the best Medicare Part D choices.
Calls to the California Poison Control System (CPCS) about abuse, primarily in adolescents, of over-the-counter medications containing the active ingredient dextromethorphan, increased tenfold from 1999 to 2004, according to a retrospective review published in the December 2006 issue of Archives of Pediatrics and Adolescent Medicine.
The UCSF School of Pharmacy maintains its ranking as the best doctor of pharmacy degree program in the United States, according to a 2005 survey conducted by U.S. News & World Report. Results were published in America's Best Graduate Schools, 2007 Edition.
But shrinking research dollars jeopardize public well-being
Robert D. Gibson, PharmD, UCSF School of Pharmacy alumnus and former associate dean, has been honored with the Chauncey I. Cooper Award by the National Pharmaceutical Association (NPhA) in recognition of his sustained and distinguished service to the profession of pharmacy.
Seeking new funding sources for PhD programs. Thank you for alumni contributions. Meeting with PharmD alumni in industry. Faculty honors and awards: Ortiz de Montellano, Voigt, Wells, England, Hunt, Bero, Day. Global activity: McGee and Drysdale (Uganda), Nguyen (Ho Chi Minh City), Guglielmo, Gwaza, Monera, Benet, Wolfe, and UCSF ranked 9th among the top 100 global universities by Newsweek International. Li Foundation becomes partner in systems biology research (Peng, Tang).
Using standards that measure a university's openness and diversity, as well as distinction in research, Newsweek International ranked UCSF 9th among the top 100 global universities as reported in the publication's August 13, 2006 online issue.
Patients benefit best from medications when they take the right medicines at the right dose and at the right time.
In the new United States Medicare Part D prescription drug plan, most people are responsible for 100% of their drug costs after their annual drug expenses exceed US$2,250 and until their expenses reach US$5,100.
Darryl Inaba, PharmD, UCSF School of Pharmacy 1971 alumnus, a substance abuse expert and former CEO of the Haight Ashbury Free Clinics, Inc., was honored on August 7, 2006 as the clinics' first fellow.
Research studies can be designed to influence the results, comments Lisa Bero, PhD, UCSF School of Pharmacy faculty member and expert on industry sponsorship of research and conflict of interest.
Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.
Candy Tsourounis, PharmD, UCSF School of Pharmacy clinical faculty member and expert on herbals and dietary supplements, warns that depending upon your blood cholesterol levels, a cholesterol-lowering dietary supplement might not be enough for you. Listen to National Public Radio Morning Edition, August 3, 2006.
In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy clinical faculty members answer questions about the contraceptive and surrounding policy issues.
Medicare Part D decisions are confusing and complex, especially to underprivileged and underserved seniors and disabled applicants. Pharmacists have the expertise to solve this problem if they were named by the Centers for Medicare and Medicaid Services (CMS) as the primary educators for the Part D benefit and appropriately funded, according to B.
Doctor of pharmacy students at the UCSF School of Pharmacy were recognized March 17, 2006 with a national Medicare Student Outreach Competition award for their success in educating the public about the new federal Medicare Prescription Drug Coverage program, known as Medicare Part D.
Robert L. Day, PharmD, UCSF School of Pharmacy associate dean and Robert D. Gibson, PharmD, alumnus and former associate dean, were honored by the American Pharmacists Association (APhA) at its 2006 annual meeting held in San Francisco, March 17 to 21, 2006.
Helene Levens Lipton, PhD, UCSF School of Pharmacy professor and health policy expert explores the impact of Medicare Part D on pharmacy business. • Full story: Pharmacists Fear Threat to Business Posed by Medicare Part D.
Marilyn Stebbins, PharmD, a clinical professor in the UCSF School of Pharmacy, is urging seniors to ask their pharmacists for help in clarifying new Medicare Part D drug benefit choices and in dealing with the government bureaucracy the benefit has spawned.
R. William Soller, PhD, executive director, UCSF School of Pharmacy Center for Consumer Self Care, is the co-recipient of the Golden Thinker Award from the North American Precis Syndicate (NAPS). The award marks record-level radio and newspaper coverage of the It's Your Life breast and prostate cancer communications campaigns.
Guglielmo named new department of clinical pharmacy chair. New faculty members: Boyd, Burchard, Cutler, Lee, MacDougall, Nkansah, Orrico, Tang, and Wells. Parfitt Pattie now oversees alumni relations in addition to fundraising. Research highlights. Honors and awards: Langridge, Giacomini, Herfindal, Gibson, Day, Nguyen, Zlott, Drysdale, and Allday. New PhD training program in systems biology. Postgraduate education of PharmD students. Employment trends of PharmD graduates.
B. Joseph Guglielmo Jr., PharmD, has been named chair of the department of clinical pharmacy, School of Pharmacy, University of California, San Francisco. The appointment is effective March 20, 2006. Guglielmo is a clinical pharmacist, researcher, and national leader on the best use of drugs to control infections.
Marilyn Stebbins, PharmD, UCSF School of Pharmacy clinical professor and drug benefit expert, explains the problems as of January 2006 with the rollout of the Medicare Part D drug benefit. She advises seniors on how to get the medication coverage that best meets their needs.
A new public board is needed to standardize, measure, and ultimately improve the quality of health care in the United States, according to UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, and University of California colleagues Stephen M. Shortell, PhD, MPH, and
Robert D. Gibson, PharmD, UCSF School of Pharmacy alumnus and former associate dean, is the 2006 recipient of the Remington Honor Medal. This is the highest honor bestowed by the American Pharmacists Association (APhA).